OpenAI 介绍 GPT-Rosalind 助力神经退行性疾病药物发现新线索
OpenAI 介绍与 @perturbai_tx 和 @scrippsresearch 合作中,GPT-Rosalind 为神经退行性疾病研究提出新线索:DCTN1 基因(关联 Perry 综合征)被扰动后,小鼠脑数据中胆固醇合成相关基因表达升高,模型推测胆固醇可能未能送达神经元所需位置,为可验证机制和潜在治疗方向。数千个 GPT-Rosalind 智能体并行工作,在 32 分钟内将数百万小鼠脑细胞的基因表达结果与科学文献关联,OpenAI 现正扩大该合作以寻找新的药物靶点。详情见 openai.com/index/scaling-ai-r…
How AI is helping scientists uncover new leads for understanding and treating neurodegenerative diseases—and the brain research behind our collaboration with @perturbai_tx and @scrippsresearch:
在 X 查看被引用的帖子GPT-Rosalind surfaced a new lead for drug discovery: could restoring cholesterol transport protect neurons from degeneration?
DCTN1 is a gene linked to Perry syndrome, a rare neurodegenerative disorder. In mouse-brain data, disrupting it increased expression of genes involved in making cholesterol. GPT-Rosalind suggested a possible explanation: cholesterol may not be reaching where neurons need it.
That gives scientists a specific mechanism to test and, if confirmed, a direction for developing new treatments for neurodegenerative disorders.
With @perturbai_tx and @scrippsresearch, a team of thousands of GPT-Rosalind agents worked in parallel, connecting gene-expression results from millions of mouse brain cells with scientific literature in just 32 minutes. We’re now expanding this collaboration to identify new drug targets.
来源:OpenAI · x.com
